India’s pharmaceutical patent regime has always sought to balance two competing objectives: encouraging genuine innovation and ensuring access to medicines. The Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026, issued by the Office of the Controller General of Patents, Designs and Trade Marks, seek to strengthen that balance through a […]